ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Left Lobe Living Donor Liver Transplantation Using Rapid Procedure in a Cirrhotic Patient with Hepatocellular Carcinoma with a GRWR of 0.35

    D. Balci1, O. Kirimker1, M. Kologlu2, U. Goktug1, E. Ustuner3, S. Karadag4, E. Er5, G. Cinar6, M. Bayar4, A. Yilmaz4, A. Azap6, K. Karayalcin1

    1General Surgery and Transplantation, Ankara University, Ankara, Turkey, 2Pediatric Surgery and Transplantation, Ankara University, Ankara, Turkey, 3Radiology, Ankara University, Ankara, Turkey, 4Anesthesiology, Ankara University, Ankara, Turkey, 5Gastroenterology, Ankara University, Ankara, Turkey, 6Infectious Disease, Ankara University, Ankara, Turkey

    *Purpose: Here, we describe a new approach using Rapid Procedure, a 2 stage hepatectomy technique, with living donor liver transplantation (LDLT) in the cirrhotic setting…
  • 2020 American Transplant Congress

    New Concept of Liver Transplatation in Pediatric Patient – Up Side Down Metod

    P. Dubska, L. Janousek, J. Chlupac, M. Kocik, J. Fronek

    Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

    *Purpose: Liver transplantation (LTx) in pediatrics has become an accepted modality for treatment in end-stage liver disease and irreversible acute liver failure. Left lateral segment…
  • 2020 American Transplant Congress

    Efficacy of Single-Strength Trimethoprim-Sulfamethoxazole Thrice Weekly for Pneumocysitis Jirovecii Pneumonia Prophylaxis Post Liver Transplantation

    A. Puing, A. Subramanian

    Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA

    *Purpose: Current guidelines recommend Pneumocystis jirovecii pneumonia (PJP) prophylaxis for at least 6-12 months after liver transplant (LTx) with preferably Trimethoprim-sulfamethoxazole (TMP-SMX) at a daily…
  • 2020 American Transplant Congress

    Transplanting Livers from Hepatitis C Virus Positive Donors; Is it Worth the Risk?

    J. W. Mensink1, B. Van Hoek2, B. Schaefer3, M. D. Van Rosmalen4, I. P. Alwayn5, A. E. Braat5

    1Leiden University Medical Center, Leiden, Netherlands, 2Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands, 3Dutch Transplant Foundation, Leiden, Netherlands, 4Eurotransplant International Foundation, Leiden, Netherlands, 5Transplant Surgery, Leiden University Medical Center, Leiden, Netherlands

    *Purpose: Before the introduction of Direct-Acting Antivirals (DAAs), only selected organs from Hepatitis C virus (HCV) positive donors were successfully transplanted into HCV positive recipients.…
  • 2020 American Transplant Congress

    Management of Pancreatic Cancer after Liver Transplantation: A 27-Year Single-Center Experience

    I. A. Ziogas, M. A. Rauf, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. P. Alexopoulos

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: The occurrence of de novo cancer after liver transplant (LT) is a leading cause of post-LT mortality and can be partially attributed to the…
  • 2020 American Transplant Congress

    Successful Transplantation of Murine Hearts Preserved 24h Under Subzero Ischemia Using Novel Bio-Inspired Next Generation Cryoprotectants

    B. Oh1, A. Callegari2, M. Kline2, A. Childs2, M. Iglesias Lozano1, G. Brandacher1, X. Wei2

    1Department of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation (VCA), Johns Hopkins University School of Medicine, Baltimore, MD, 2X-Therma Inc., Richmond, CA

    *Purpose: Extension of the organ ischemia window is of paramount importance to prolong viability of transplantable organs and to improve overall outcomes. Transport using a…
  • 2020 American Transplant Congress

    The Effects of Rivaroxaban and Apixaban on Tacrolimus Pharmacokinetics

    A. C. Scheibner1, C. Franco-Martinez1, E. Kincaide1, R. Hall1, C. Long2

    1Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin, University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Feik School of Pharmacy, University of the Incarnate Word, University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX

    *Purpose: To clarify the pharmacokinetic impact of rivaroxaban (RIVA) and apixaban (APIX) on tacrolimus (TAC) concentrations.*Methods: Solid organ transplant recipients 18-years or older who were…
  • 2020 American Transplant Congress

    Envarsus XR Use Can Benefit Serum Creatinine Levels in Vascularized Composite Allotransplantation Patients

    C. M. Cooney1, V. Javia1, J. Littleton1, D. S. Cooney1, R. J. Redett1, J. T. Shores1, D. C. Brennan2, G. Brandacher1

    1Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Surgery, Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Vascularized composite allotransplantation (VCA) is a life-enhancing (as opposed to life-saving) procedure. Therefore, minimizing adverse outcomes associated with chronic immunosuppression is vital to determining…
  • 2020 American Transplant Congress

    Non-HLA Antibodies in Severe Post-Operative Thrombotic Microangiopathy among Kidney Transplant Recipients

    R. Bonakdar, P. Serrano Rodriguez

    University of North Carolina Hospitals, Chapel Hill, NC

    *Purpose: From August 2018 until July 2019, an alarming 6% of kidney transplant recipients at this transplant center had biopsy-proven thrombotic microangiopathy (TMA) within 1…
  • 2020 American Transplant Congress

    Microvascular Inflammation without DSA or C4d: An Orphan Category in Banff Classification with Intense Capillaritis and Cytotoxic T-Cell Infiltration

    A. Buxeda1, L. Llinàs-Mallol2, J. Gimeno3, C. Arias-Cabrales1, C. Burballa1, D. Redondo-Pachón1, D. Raïch-Regué2, M. Pérez-Sáez1, J. Pascual1, M. Crespo1

    1Nephrology Department, Hospital del Mar, Barcelona, Spain, 2Nephrology Department, IMIM - Institute Hospital del Mar for Medical Research, Barcelona, Spain, 3Pathology Department, Hospital del Mar, Barcelona, Spain

    *Purpose: Antibody-mediated rejection (ABMR) associated with donor-specific HLA antibodies (DSA) is the leading cause of late allograft failure after kidney transplantation. Microvascular inflammation (MVI) without…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences